Who has invested in Cambrian Biopharma?

Korify Capital are named among the investors backing Cambrian Biopharma.

Cambrian Biopharma Funding: $100M Raised, Series C

Cambrian Biopharma funding overview

Cambrian Biopharma is based in New York, New York. Cambrian Biopharma has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C. Investors on record include Korify Capital.

Cambrian Biopharma at a glance

Total raised: $100M
Latest round: Series C
Headquarters: New York, New York
Notable investors: Korify Capital

Frequently asked about Cambrian Biopharma funding

How much has Cambrian Biopharma raised?: Cambrian Biopharma has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Cambrian Biopharma?: Korify Capital are named among the investors backing Cambrian Biopharma.
What was the latest Cambrian Biopharma funding round?: The most recent disclosed round is a Series C.
Where is Cambrian Biopharma based?: Cambrian Biopharma is based in New York, New York.

Round data for Cambrian Biopharma is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in New York and backer lists below.

Cambrian Biopharma Funding: $100M Raised, Series C

Cambrian Biopharma funding overview

Cambrian Biopharma at a glance

Frequently asked about Cambrian Biopharma funding

Companies related to Cambrian Biopharma (18)

Browse related funding lists (4)